EUVIMEDEUVIMED entdecken
Open Access

Feasibility and Acceptability of a Mobile App to Improve Quality of Life of Long-Term Breast Cancer Survivors: Single-Arm Pre-Post Intervention Pilot Study

Nelia Soto-Ruiz iD, Gustavo Adolfo Pimentel Parra iD, Paula Escalada-Hernández iD, Cristina García-Vivar iD

JMIR Cancer · 04.11.2025 · 11 · e76719-e76719

DOI: 10.2196/76719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Cancer, online erschienen am 04.11.2025. Verfasst von Nelia Soto-Ruiz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Public University of Navarre, Avda. Barañain s/n, Pamplona, 31600, Spain, (+34) 948 16 61 50. Hauptthemen laut MEDLINE: Quality of Life, Mobile Applications, Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term breast cancer survivors often continue to experience physical and psychological sequelae, despite being cancer-free; these challenges can negatively impact their quality of life and self-efficacy. Mobile health interventions constitute a promising strategy for providing personalized support. However, the feasibility and acceptability of these tools in long-term breast cancer survivors have not yet been sufficiently explored.

Objective

This study aimed to evaluate the feasibility and acceptability of the CUMACA-M, a digital health app designed to improve the quality of life and self-efficacy in long-term breast cancer survivors.

Methods

A single-arm feasibility pilot study was conducted with pre- and post-intervention evaluations. Participants were recruited from the Navarra Breast Cancer Association (Saray), a nonprofit organization supporting individuals with breast cancer in Navarra, Spain. The inclusion criteria included being female, being aged ≥18 years, having been diagnosed with breast cancer, and being disease-free for at least 5 years after primary treatment. The participants used the CUMACA-M app for 3 months. Feasibility was assessed through recruitment and completion rates, whereas acceptability was measured using the System Usability Scale and open-ended qualitative questions. Changes in quality of life and self-efficacy were analyzed with the Quality of Life-Cancer Survivors (QOL-CS) scale and the Self-Efficacy to Manage Chronic Disease Scale. Paired t tests were performed for pre-post comparisons.

Results

A total of 23 women (mean age =52.8, SD 6.1 years) participated, with a 100% retention rate. The System Usability Scale score (mean 80.8, SD 15.2) indicated excellent usability. The health advice module received the highest level of satisfaction, whereas the nutrition and physical activity modules received suggestions for improvement. With respect to the clinical outcomes, no statistically significant differences were found between the pre- and post-intervention scores on the QOL-CS (total score: pre=5.96, SD 1.08; post=5.72, SD 1.20; P =.07) or the Self-Efficacy to Manage Chronic Disease Scale (total score: pre=6.57, SD 1.90; post=6.26, SD 1.82; P =.40). However, a reduction was observed in the QOL-CS spiritual well-being subscale (pre=5.35, SD 1.13; post=4.93, SD 1.22; P =.05).

Conclusions

As a pioneering digital intervention for long-term breast cancer survivors, CUMACA-M appears to be a potentially viable and acceptable intervention for this population, as suggested by the high level of usability and absence of dropouts. However, the findings should be interpreted with caution because of the limited sample size and the short follow-up period. The lack of significant changes in quality of life or self-efficacy may be influenced by these constraints. Future studies with larger, more diverse samples and longer follow-up periods are needed to more robustly assess the long-term impact of this intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeMobile ApplicationsBreast NeoplasmsCancer SurvivorsHumansFemalePilot ProjectsFeasibility StudiesMiddle AgedSelf EfficacyAdultAgedTelemedicine

Stichwörter der Autor:innen

breast cancer survivorsdigital healthfeasibility studymHealth appsmobile healthquality of lifeself-efficacy

Autor:innen und Institutionen

  • Department of Health Sciences, Public University of Navarre, Avda. Barañain s/n, Pamplona, 31600, Spain, (+34) 948 16 61 50.
  • Navarre Institute of Health Research, Pamplona, Spain.

ORCID-Profile: Nelia Soto-Ruiz, Gustavo Adolfo Pimentel Parra, Paula Escalada-Hernández, Cristina García-Vivar

Zitieren

APA

Soto-Ruiz, N., Pimentel Parra, G. A., Escalada-Hernández, P., & García-Vivar, C. (2025). Feasibility and Acceptability of a Mobile App to Improve Quality of Life of Long-Term Breast Cancer Survivors: Single-Arm Pre-Post Intervention Pilot Study. JMIR Cancer, 11, e76719-e76719. https://doi.org/10.2196/76719

Vancouver

Soto-Ruiz N, Pimentel Parra GA, Escalada-Hernández P, García-Vivar C. Feasibility and Acceptability of a Mobile App to Improve Quality of Life of Long-Term Breast Cancer Survivors: Single-Arm Pre-Post Intervention Pilot Study. JMIR Cancer. 2025;11:e76719-e76719. doi:10.2196/76719

BibTeX
@article{SotoRuiz2025,
  author = {Soto-Ruiz, Nelia and Pimentel Parra, Gustavo Adolfo and Escalada-Hernández, Paula and García-Vivar, Cristina},
  title = {Feasibility and Acceptability of a Mobile App to Improve Quality of Life of Long-Term Breast Cancer Survivors: Single-Arm Pre-Post Intervention Pilot Study},
  journal = {JMIR Cancer},
  year = {2025},
  volume = {11},
  pages = {e76719--e76719},
  doi = {10.2196/76719}
}
Kostenlos starten →